- Posts: 1127
- Thank you received: 276
1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.1980.hed2001013.x/abstract
Platelet Antagonists in Migraine Prophylaxis A Clinical Trial Using Aspirin and Dipyridamole [Persantine]
Brent E. Masel M.D.,
Andrew L. Chesson M.D.,
Bruce H. Peters M.D.,
Harvey S. Levin Ph.D.,
Jack B. Alperin M.D.
Article first published online: 22 JUN 2005
DOI: 10.1111/j.1526-4610.1980.hed2001013.x
SYNOPSIS
The platelet hyperaggregability of the migraine population has lead us to postulate that platelet antagonists might be effective in migraine prophylaxis.
A double-blind cross-over study of aspirin, 325 mg BID, combined with dipyridamole, 25 mg TID, compared to placebo and pretreatment conditions was undertaken. Platelet aggregation studies were done during the three month active medication and placebo periods.
In patients with platelet hyperaggregability significant improvement occurred in headache frequency, intensity, and limitation of activity with no change in headache duration. Regardless of platelet aggregability, the 25 patients comprising the total sample significantly improved as compared to placebo. Sixty-eight percent of the patients tested reported subjective improvement while taking the active medication. No side effects related to the medication were reported and no patients, including those who withdrew from the study for other reasons, reported worsening of headache while on the active medication.
Although the significance of platelet hyperaggregability in migraine patients, and the pharmacological effect of aspirin and dipyridamole on this, is unclear, these medications may have potential as a method of migraine prophylaxis.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.

Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Katsim wrote: I just thought I'd add this thought on platelet lifespan - in November last year I had an indium platelet scan. My count was hovering at around 100 and the scan results showed that my platelets "lived" for about 26 hours. Just thought you might be interested to know it can be as short as that
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Sandi wrote: Rob:
If a person has the APS antibodies, they are not usually treated with blood thinners until they experience a clot. The only mode of prevention is aspirin and according to research, there is no proof that it prevents anything. In Ellen's case it seems to prevent migraines and that is fantastic. But! With her counts so unstable, you need to be careful. I was told to take the 89 mg aspirin tablets and am not supposed to take them with counts below 50k.
Low platelets and blood thinners are difficult to balance and it should be done with a doctor's approval and careful monitoring.
Please Log in or Create an account to join the conversation.
Ann wrote: It wouldn't be normal though. Normal life means not ITP.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Rob16 wrote: Separate topic: we also discussed antiphospholipid antibody testing, and the hema said she could see no point in it, as it would not change Ellen’s treatment as long as there was no history of thrombosis. Hard to argue with that.
Please Log in or Create an account to join the conversation.
Ellen's hema wants to combine Rituxan with high-dose dexamethasone. That seems to be the original protocol; she claims the combination is more effective, but I find nothing nothing that shows it is more effective than Rituxan alone (only that it is more effective than dexamethasone alone).Sandi wrote: Rituxan is a decent choice at this point. I never got sick after I'd had it. You still have plenty of immune system left to tackle illnesses. As long as you don't mix it with steroids and splenectomy, it's not so bad.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Platelet Disorder Support Association
8751 Brecksville Road Suite 150
Cleveland, OH 44141
440.746.9003 | pdsa@pdsa.org
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.
© Copyright 1997 - 2026, Platelet Disorder Support Association. All rights reserved.
IMPORTANT!
The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.